Stroke Recovery Initiative - Registry for Stroke Research Studies
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Oct 18, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Stroke Recovery Initiative is a national program designed to connect individuals who have experienced a stroke with researchers looking to improve recovery methods. This study is focused on gathering information from people who have had strokes, whether they were caused by a blockage (ischemic stroke) or bleeding in the brain (hemorrhagic stroke). By participating, you can help researchers understand the challenges faced during recovery and contribute to the development of new treatments and therapies.
To be eligible for this study, you need to be at least 18 years old and have had a stroke that has left you with ongoing symptoms. If you decide to participate, you will be part of a registry, meaning you'll provide information that may help shape future stroke recovery research. This initiative welcomes individuals of all genders and is currently recruiting participants. Your involvement could make a difference in advancing the care and recovery of others who have experienced a stroke.
Gender
ALL
Eligibility criteria
- • 18 years of age or older
- • Have suffered a stroke
- • Have ongoing symptoms as a result of the stroke
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Anthony S. Kim, MD, MAS
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials